The team at Boast polled more than 500 CXOs in R&D-focused organizations across North America to baseline how businesses are funding innovation and product development in 2023.
As it turns out, many executives have been squarely focused on the essentials for their business in the face of major macroeconomic uncertainties in 2024, while leaving little budget for risk-taking, leading to missed growth opportunities—including non-equity funding through tax credits.
Check out this infographic for a primer on the results and the opportunities for teams to capitalize on innovation in 2025.
To read our full analysis, download the 2024 State of R&D Benchmarks Report eBook, or dig into the full results doc here for all the data from our CXO survey.
